Regulatory Open Forum

 View Only
  • 1.  Identifying Device Cleared for Pediatric Population

    Posted 31-Jan-2023 12:05
    If a device is cleared in the US for pediatric use, is that information always included in the Indications for Use portion of a 510(k) summary or is it possible to have it buried in the equivalence table under target population or somewhere else? Phrased a different way, my question is if a device's Indications for Use fail to mention any age range (e.g.: "device is intended to perform function X in population age Y and above"), is it assumed that the device is only cleared for the adult population?

    ------------------------------
    Ian Boland
    Regulatory Affairs Specialist
    NJ
    United States
    ------------------------------


  • 2.  RE: Identifying Device Cleared for Pediatric Population

    Posted 01-Feb-2023 06:17
    Hello Ian,

    Unfortunately this is one of the fallacies and inconsistencies within the US regulatory system for medical devices (assume talking about 510(k)).  The FDA has gotten better in the last 10 years about including patient age range in the indications for use/intended use or making clear statements like, 'adult population' which is assumed 21 years and older (defined by the FD&C Act).  To answer your question, yes you will need to search through the 510(k) Summary or the Intended Use/Indications for Use statement to understand if this is clearly specified.  I have spoken with some reviewers and investigators over the years which the general stance is as you said: if not specified it is assumed only cleared for adult population.  As said before, higher risk devices and implants the US FDA has gotten more detailed in these type of products to clearly identify if can be used in a paediatric population or not.

    ------------------------------
    Richard Vincins ASQ-CQA, MTOPRA, RAC
    Vice President Global Regulatory Affairs
    ------------------------------



  • 3.  RE: Identifying Device Cleared for Pediatric Population

    Posted 01-Feb-2023 08:16

     

     

    Richard, I'm not in 100% agreement that it's a good thing to be highly specific about populations in indications for use.  In my experience, doing so has the unfortunate consequence of creating off label use.  In many cases, general tools (e.g., catheters) may have utility in pediatrics but not generate enough revenue for collection of the data that may be requested by regulators to support that specific use.

     

    I think all of us would like to see data that supports all intended uses, but when the process becomes overly complex/burdensome the product availability can suffer.  It's a bit like humanitarian device issues.

     

    It's a tough topic, to be sure.

     

    Best regards,

     

    Ted

     

     

     

     






  • 4.  RE: Identifying Device Cleared for Pediatric Population

    Posted 01-Feb-2023 09:36
    Oh Ted, does not mean I would say this absolutely needs to be done.  What I was referring to about inconsistency is having a place in the regulations or having a way regulators can clearly indicate age range of product use ... if needed.  Completely agree setting the age of devices can be quite limiting, but at the same time I think there are some devices which needs to be specified.  That was what I was referring is having a way to indicate whether a device should clearly indicate paediatric populations or not or specify an age range.  As example, it is already known some implants are only intended or should only be intended for adult populations.

    ------------------------------
    Richard Vincins ASQ-CQA, MTOPRA, RAC
    Vice President Global Regulatory Affairs
    ------------------------------



  • 5.  RE: Identifying Device Cleared for Pediatric Population

    Posted 01-Feb-2023 09:39

     

     

     

    We are on the same page, Richard, as usual.

     

    I was not disagreeing with you so much as qualifying it a bit.  And taking an opportunity for a mild rant too.

     

    :)

     

     

     

     






  • 6.  RE: Identifying Device Cleared for Pediatric Population

    Posted 01-Feb-2023 14:28
    Thank you, Richard and Ted! 

    To summarize, explicit indication for use with a pediatric population may be expected by the FDA in a 510(k), but the FDA is more concerned with devices where the use with a pediatric population could introduce a significant risk. 

    Therefore, within the context of pediatric vs adult populations, a device manufacturer can typically market a 510(k) cleared device without discrimination for age of target population so long as it doesn't introduce unreasonable risk to the pediatric population.

    Is this an accurate understanding of your experiences?

    ------------------------------
    Ian Boland
    Regulatory Affairs Specialist
    NJ
    United States
    ------------------------------



  • 7.  RE: Identifying Device Cleared for Pediatric Population

    Posted 02-Feb-2023 13:39

     

     

    Hi Ian,

     

    I think the consideration of possible risks certainly comes into the CDRH decision-making process here, but I'm not convinced there's anything that could be considered typical in this matter.  I'd be interested in Richard's thoughts, if he's able to comment further.

     

    Best regards,

     

    Ted

     

     

     






  • 8.  RE: Identifying Device Cleared for Pediatric Population

    Posted 03-Feb-2023 04:28
    Hello Ian,

    Yes, in basic understanding that is correct.  As you can imagine due to the variety and variations of medical devices, there are always exceptions and some FDA reviewers have different methods reviewing 510(k)s and thoughts on population (had one reviewer who always wanted it specified as "adult").  However in general, if age of population or demographics are not specifically required in the 510(k) submission/clearance than can/would assume any age.  Myself personally, internal documentation would always describe the intended users, intended patients, age groups, demographics, etc., but this may not become part of the intended use/indications for use statement.

    ------------------------------
    Richard Vincins ASQ-CQA, MTOPRA, RAC
    Vice President Global Regulatory Affairs
    ------------------------------



  • 9.  RE: Identifying Device Cleared for Pediatric Population

    Posted 03-Feb-2023 11:37
    Thank you, both!

    This feedback has been very insightful. I'm grateful that you both took the time to share with me.

    ------------------------------
    Ian Boland
    Regulatory Affairs Specialist
    NJ
    United States
    ------------------------------